サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1521384

うっ血性心不全治療装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Congestive Heart Failure Treatment Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
うっ血性心不全治療装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

うっ血性心不全治療装置市場の世界需要は、2023年の282億2,000万米ドルから2032年には約521億4,000万米ドルの市場規模に達すると推定され、調査期間2024-2032年のCAGRは7.06%です。

うっ血性心不全（CHF）治療装置には、心不全の症状を管理・改善するために特別に設計された多様な医療装置が含まれます。これらの装置は、心臓が効率的に血液を送り出すのに苦労し、肺や体の他の部位に体液が蓄積する慢性疾患であるCHF患者に治療上のサポートを提供する上で重要な役割を果たしています。うっ血性心不全治療装置の主な目的は、心機能を高め、症状を緩和し、患者の全体的な生活の質を高めることです。

市場力学

うっ血性心不全治療装置市場は、世界の心不全有病率の増加、特に高齢者人口の増加に牽引され、大きな成長を遂げています。平均寿命が延び、ライフスタイルが進化するにつれて、心不全の発生率は上昇を続けており、ペースメーカー、植え込み型除細動器（ICD）、心臓再同期療法（CRT）などの植え込み型デバイスを含む高度な治療オプションが必要となっています。心臓治療における技術的進歩も市場成長の極めて重要な促進要因です。装置の小型化、遠隔モニタリングのためのワイヤレス接続、バッテリー寿命の改善などの技術革新により、うっ血性心不全治療装置の有効性と使いやすさが向上しています。これらの進歩は、医療提供者にリアルタイムのデータを提供することで患者の転帰を改善し、個別化されたタイムリーな介入を通じて慢性疾患のより良い管理に貢献しています。

さらに、有利な償還政策と医療費の増加が市場の拡大を後押ししています。政府やヘルスケア機関は、心不全のような慢性疾患を管理するための予防策や高度な治療オプションの費用対効果をますます認識するようになっており、うっ血性心不全治療装置の採用を後押ししています。しかし、装置の移植やメンテナンスに伴う初期コストの高さや、装置の承認や患者の安全性に関する規制要件の厳しさが、中小のうっ血性心不全治療装置メーカーにとっては市場参入の障壁となっています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、うっ血性心不全治療装置の世界市場における各セグメントを包括的に評価することもできます。うっ血性心不全治療装置産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

うっ血性心不全治療装置市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会とともに、それぞれの製品やサービスのターゲット層を特定するのに役立ちます。

製品別

  • 除細動器（植込み型除細動器（ICD）（経静脈ICD（単室ICD、複室ICD）、皮下ICD））
  • 体外式除細動器（手動式体外式除細動器、自動式体外式除細動器（半自動式体外式除細動器、全自動式体外式除細動器）、装着型体外式除細動器）
  • ペースメーカー（植込み型ペースメーカー、体外式ペースメーカー）
  • 心臓再同期療法装置（心臓再同期除細動器（CRT-D）（MRI対応CRT-D装置、従来型CRT-D装置）、心臓再同期療法ペースメーカ（CRT-P）（MRI対応CRT-P装置、従来型CRT-P装置））
  • 補助人工心臓（左心室補助人工心臓、右心室補助人工心臓、両心室補助人工心臓、経皮的心室補助人工心臓、全人工心臓）
  • その他の製品

エンドユーザー別

  • 病院
  • 心臓クリニック
  • 外来手術センター
  • その他のエンドユーザー

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおけるうっ血性心不全治療装置市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 うっ血性心不全治療装置- 産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 うっ血性心不全治療デバイスの世界市場分析：製品別

  • 製品別概要
  • 製品別の過去および予測データ分析
  • 除細動器（植込み型除細動器（ICD）（経静脈ICD（単室ICD、複室ICD）、皮下ICD））
  • 体外式除細動器（手動式体外式除細動器、自動式体外式除細動器（半自動式体外式除細動器、全自動式体外式除細動器）、装着型体外式除細動器）
  • ペースメーカー（植込み型ペースメーカー、体外式ペースメーカー）
  • 心臓再同期療法装置（心臓再同期除細動器（CRT-D）（MRI対応CRT-D装置、従来型CRT-D装置）、心臓再同期療法ペースメーカ（CRT-P）（MRI対応CRT-P装置、従来型CRT-P装置））
  • 補助人工心臓（左心室補助人工心臓、右心室補助人工心臓、両心室補助人工心臓、経皮的心室補助人工心臓、全人工心臓）
  • その他の製品

第6章 うっ血性心不全治療デバイスの世界市場分析：最終用途別

  • 最終用途別概要
  • 最終用途別の過去および予測データ分析
  • 病院
  • 心臓クリニック
  • 外来手術センター
  • その他のエンドユーザー

第7章 うっ血性心不全治療装置の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第8章 うっ血性心不全治療デバイス企業の競合情勢

  • うっ血性心不全治療装置市場競争
  • 提携/協力/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninkilijke Philips N.V.
  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Medico S.P.A.
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Oscor Inc.
  • Schiller AG
  • Shree Pacetronix Ltd.
  • St. Jude Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Congestive Heart Failure Treatment Device Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Congestive Heart Failure Treatment Device Report
  • Market Research Process
  • Market Research Methodology
  • Global Congestive Heart Failure Treatment Device Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115266

The global demand for Congestive Heart Failure Treatment Device Market is presumed to reach the market size of nearly USD 52.14 Billion by 2032 from USD 28.22 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Congestive Heart Failure (CHF) treatment devices encompass a diverse range of medical devices specifically designed to manage and improve the symptoms of heart failure. These devices play a crucial role in providing therapeutic support to patients with CHF, a chronic condition in which the heart struggles to efficiently pump blood, leading to fluid accumulation in the lungs other areas of the body. The primary goal of congestive heart failure treatment devices is to enhance cardiac function, alleviate symptoms, and enhance patients' overall quality of life.

MARKET DYNAMICS

The CHF treatment device market is witnessing significant growth driven by the increasing prevalence of heart failure globally, particularly among elderly populations. As life expectancy rises and lifestyles evolve, the incidence of heart failure continues to escalate, necessitating advanced treatment options, including implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Technological advancements in cardiac care are also pivotal drivers of market growth. Innovations such as miniaturization of devices, wireless connectivity for remote monitoring, and improved battery life are enhancing the efficacy and usability of congestive heart failure treatment devices. These advancements improve patient outcomes by providing real-time data to healthcare providers and contribute to better management of chronic conditions through personalized and timely interventions.

Moreover, favorable reimbursement policies and increasing healthcare expenditure are bolstering market expansion. Governments and healthcare organizations increasingly recognize the cost-effectiveness of preventive measures and advanced treatment options for managing chronic diseases like heart failure, thereby supporting the adoption of congestive heart failure treatment devices. However, the high initial costs associated with device implantation and maintenance and stringent regulatory requirements for device approval and patient safety pose barriers to market entry for smaller congestive heart failure treatment device manufacturers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Congestive Heart Failure Treatment Device. The growth and trends of Congestive Heart Failure Treatment Device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Congestive Heart Failure Treatment Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD))
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator)
  • Pacemakers (Implantable Pacemakers, External Pacemakers)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices))
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart)
  • Other Products

By End-Use

  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgical Centers
  • Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Congestive Heart Failure Treatment Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Congestive Heart Failure Treatment Device market include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninkilijke Philips N.V., Lepu Medical Technology Co. Ltd., LivaNova PLC, Medico S.P.A., Medtronic Plc, MicroPort Scientific Corporation, Oscor Inc., Schiller AG, Shree Pacetronix Ltd., St. Jude Medical Inc., Stryker Corporation, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CONGESTIVE HEART FAILURE TREATMENT DEVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Historic and Forecast Sales By Regions
  • 5.4. External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Historic and Forecast Sales By Regions
  • 5.5. Pacemakers (Implantable Pacemakers, External Pacemakers) Historic and Forecast Sales By Regions
  • 5.6. Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Historic and Forecast Sales By Regions
  • 5.7. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Historic and Forecast Sales By Regions
  • 5.8. Other Products Historic and Forecast Sales By Regions

6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data Analysis By End-Use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Clinics Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Other End-Users Historic and Forecast Sales By Regions

7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONGESTIVE HEART FAILURE TREATMENT DEVICE COMPANIES

  • 8.1. Congestive Heart Failure Treatment Device Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CONGESTIVE HEART FAILURE TREATMENT DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Biotronik SE & Co. KG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Koninkilijke Philips N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Lepu Medical Technology Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. LivaNova PLC
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medico S.P.A.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Medtronic Plc
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. MicroPort Scientific Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Oscor Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Schiller AG
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Shree Pacetronix Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. St. Jude Medical Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Stryker Corporation
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Terumo Corporation
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies